Cost-effectiveness of a randomised trial of physical activity in Alzheimer’s disease: A secondary analysis exploring patient and proxy-reported health-related quality of life measures in Denmark (BMJ Open, 2017, 7(6))

To explore the cost-effectiveness of a supervised moderate-To-high intensity aerobic exercise programme in people diagnosed with Alzheimer’s disease (AD) and estimate incremental cost-effectiveness ratios (ICER) using participant-reported and proxy-reported measures of health-related quality of life (HRQoL) Design A cost-effectiveness analysis of economic and HRQoL data from a randomised trial delivered over 16 weeks. Setting Memory clinics in Denmark.

Access the paper by clicking here.